Keywords: gsk, enters, boron, drug, accord, anacor, usa
GSK enters boron drug R&D accord with Anacor
Article | 15 October 2007
The USA's Anacor Pharmaceuticals and UK drug major GlaxoSmithKline have entered into a worldwide strategic alliance for the discovery, development ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
